Research identifies a distinct immune signature in treatment-resistant Myasthenia Gravis
February 20, 2026
February 20, 2026
MANCHESTER, England, Feb. 20 -- The University of Manchester issued the following news release:
* * *
Research identifies a distinct immune signature in treatment-resistant Myasthenia Gravis
*
Myasthenia Gravis (MG) is a rare autoimmune disease in which the immune system attacks the connection between nerves and muscles. This attack causes muscle weakness that can affect vision, movement, speech, swallowing, and breathing. While many patients r . . .
* * *
Research identifies a distinct immune signature in treatment-resistant Myasthenia Gravis
*
Myasthenia Gravis (MG) is a rare autoimmune disease in which the immune system attacks the connection between nerves and muscles. This attack causes muscle weakness that can affect vision, movement, speech, swallowing, and breathing. While many patients r . . .